429 related articles for article (PubMed ID: 29372858)
61. Outcomes of patients with spinal metastases from renal cell carcinoma treated with conventionally-fractionated external beam radiation therapy.
Lee CC; Tey JCS; Cheo T; Lee CH; Wong A; Kumar N; Vellayappan B
Medicine (Baltimore); 2020 Apr; 99(16):e19838. PubMed ID: 32312006
[TBL] [Abstract][Full Text] [Related]
62. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D
BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687
[TBL] [Abstract][Full Text] [Related]
63. Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapy.
Barry A; McPartlin A; Lindsay P; Wang L; Brierley J; Kim J; Ringash J; Wong R; Dinniwell R; Craig T; Dawson LA
Pract Radiat Oncol; 2017; 7(5):e331-e337. PubMed ID: 28442242
[TBL] [Abstract][Full Text] [Related]
64. Delayed radiation-induced myelopathy after spinal radiosurgery.
Gibbs IC; Patil C; Gerszten PC; Adler JR; Burton SA
Neurosurgery; 2009 Feb; 64(2 Suppl):A67-72. PubMed ID: 19165076
[TBL] [Abstract][Full Text] [Related]
65. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
[TBL] [Abstract][Full Text] [Related]
66. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
[TBL] [Abstract][Full Text] [Related]
67. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery.
Farooqi A; Bishop AJ; Narang S; Allen PK; Li J; McAleer MF; Tatsui CE; Rhines LD; Amini B; Wang XA; Ghia AJ
Pract Radiat Oncol; 2019 Mar; 9(2):e142-e148. PubMed ID: 30385151
[TBL] [Abstract][Full Text] [Related]
68. Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary results.
Lubgan D; Ziegaus A; Semrau S; Lambrecht U; Lettmaier S; Fietkau R
Strahlenther Onkol; 2015 Mar; 191(3):264-71. PubMed ID: 25395089
[TBL] [Abstract][Full Text] [Related]
69. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
70. Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E
Christ SM; Alongi F; Ricardi U; Scorsetti M; Livi L; Balermpas P; Lievens Y; Braam P; Jereczek-Fossa BA; Stellamans K; Ratosa I; Widder J; Peulen H; Dirix P; Bral S; Ramella S; Hemmatazad H; Khanfir K; Geets X; Jeene P; Zilli T; Fournier B; Ivaldi GB; Clementel E; Fortpied C; Oppong FB; Ost P; Guckenberger M
Radiother Oncol; 2024 Jun; 195():110235. PubMed ID: 38508239
[TBL] [Abstract][Full Text] [Related]
71. No association between excessive wound complications and preoperative high-dose, hypofractionated, image-guided radiation therapy for spine metastasis.
Keam J; Bilsky MH; Laufer I; Shi W; Zhang Z; Tam M; Zatcky J; Lovelock DM; Yamada Y
J Neurosurg Spine; 2014 Apr; 20(4):411-20. PubMed ID: 24506099
[TBL] [Abstract][Full Text] [Related]
72. Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.
Moore-Palhares D; Zeng KL; Tseng CL; Chen H; Myrehaug S; Soliman H; Maralani P; Larouche J; Shakil H; Jerzak K; Ruschin M; Zhang B; Atenafu EG; Sahgal A; Detsky J
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1110-1121. PubMed ID: 38395085
[TBL] [Abstract][Full Text] [Related]
73. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
[TBL] [Abstract][Full Text] [Related]
74. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer.
Seymour ZA; Chang AJ; Zhang L; Kirby N; Descovich M; Roach M; Hsu IC; Gottschalk AR
Pract Radiat Oncol; 2015; 5(5):e465-e472. PubMed ID: 25795252
[TBL] [Abstract][Full Text] [Related]
75. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
[TBL] [Abstract][Full Text] [Related]
76. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
77. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
[TBL] [Abstract][Full Text] [Related]
78. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
[TBL] [Abstract][Full Text] [Related]
79. Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy.
Puvanesarajah V; Lo SL; Aygun N; Liauw JA; Jusué-Torres I; Lina IA; Hadelsberg U; Elder BD; Bydon A; Bettegowda C; Sciubba DM; Wolinsky JP; Rigamonti D; Kleinberg LR; Gokaslan ZL; Witham TF; Redmond KJ; Lim M
J Neurosurg Spine; 2015 Nov; 23(5):620-629. PubMed ID: 26230422
[TBL] [Abstract][Full Text] [Related]
80. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
